Deerfield Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-471,000
Closed -$67.8M 164
2025
Q3
$67.8M Sell
471,000
-229,700
-33% -$28.1M 1.04% 28
2025
Q2
$70.5M Buy
700,700
+242,700
+53% +$18.6M 1.28% 21
2025
Q1
$34.9M Buy
+458,000
New +$35M 0.69% 35
2024
Q4
Sell
-52,861
Closed -$3.86M 257
2024
Q3
$3.86M Buy
52,861
+41,502
+365% +$3.06M 0.06% 72
2024
Q2
$761K Buy
+11,359
New +$441K 0.01% 188
2023
Q3
Sell
-658,546
Closed -$13.9M 97
2023
Q2
$13.9M Hold
658,546
0.3% 59
2023
Q1
$11.2M Sell
658,546
-5,600
-0.8% -$109K 0.25% 68
2022
Q4
$13.3M Sell
664,146
-296,338
-31% -$5.73M 0.27% 67
2022
Q3
$20.7M Hold
960,484
0.41% 62
2022
Q2
$18.9M Buy
960,484
+655,912
+215% +$13.7M 0.39% 62
2022
Q1
$7.16M Buy
+304,572
New +$7.08M 0.16% 79
2021
Q3
Sell
-200,000
Closed -$5.69M 145
2021
Q2
$5.69M Buy
+200,000
New +$5.94M 0.1% 127
2015
Q3
Sell
-891,546
Closed -$21.8M 142
2015
Q2
$21.8M Sell
891,546
-736,985
-45% -$16.7M 0.73% 50
2015
Q1
$33.9M Sell
1,628,531
-613,100
-27% -$10.8M 1.1% 24
2014
Q4
$34.7M Buy
2,241,631
+161,471
+8% +$2.29M 1.25% 26
2014
Q3
$27.1M Buy
2,080,160
+874,926
+73% +$13.2M 0.99% 34
2014
Q2
$24.1M Sell
1,205,234
-810,913
-40% -$12M 0.97% 35
2014
Q1
$38.4M Buy
2,016,147
+963,902
+92% +$18.3M 1.57% 18
2013
Q4
$17.9M Buy
1,052,245
+121,495
+13% +$1.86M 0.93% 41
2013
Q3
$14.5M Buy
930,750
+376,957
+68% +$4.79M 0.68% 54
2013
Q2
$6.62M Buy
+553,793
New +$5.66M 0.31% 73

Other funds holding INSM

Deerfield Management's INSM Position: Q4 2025 in Review

Deerfield Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 471,000 shares — an estimated $67.8M sold.

Deerfield Management first reported a position in INSM in Q2 2013 and held it in 21 quarters. The position peaked at $70.5M in Q2 2025. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Deerfield Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Deerfield Management sold 471,000 Insmed shares in Q4 2025, an estimated $67.8M.
  • Deerfield Management first reported a position in Insmed in Q2 2013 and held it in 21 quarters.
  • Deerfield Management's Insmed position peaked at $70.5M in Q2 2025.
  • 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Deerfield Management's 13F filing for Q4 2025, filed 17 Feb 2026.